101 related articles for article (PubMed ID: 22700770)
1. Epigenomic silencing of the BMP-4 gene in pituitary adenomas: a potential target for epidrug-induced re-expression.
Yacqub-Usman K; Duong CV; Clayton RN; Farrell WE
Endocrinology; 2012 Aug; 153(8):3603-12. PubMed ID: 22700770
[TBL] [Abstract][Full Text] [Related]
2. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes.
Yacqub-Usman K; Duong CV; Clayton RN; Farrell WE
Endocrinology; 2013 May; 154(5):1711-21. PubMed ID: 23539512
[TBL] [Abstract][Full Text] [Related]
3. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics of pituitary tumours: an update.
Farrell WE
Curr Opin Endocrinol Diabetes Obes; 2014 Aug; 21(4):299-305. PubMed ID: 24983395
[TBL] [Abstract][Full Text] [Related]
5. The EFEMP1 gene: a frequent target for epigenetic silencing in multiple human pituitary adenoma subtypes.
Duong CV; Yacqub-Usman K; Emes RD; Clayton RN; Farrell WE
Neuroendocrinology; 2013; 98(3):200-11. PubMed ID: 24080855
[TBL] [Abstract][Full Text] [Related]
6. Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis.
Al-Azzawi H; Yacqub-Usman K; Richardson A; Hofland LJ; Clayton RN; Farrell WE
Endocrinology; 2011 Feb; 152(2):364-73. PubMed ID: 21177832
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.
Bahar A; Bicknell JE; Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2004 Jan; 23(4):936-44. PubMed ID: 14647444
[TBL] [Abstract][Full Text] [Related]
8. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
9. Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas.
Duong CV; Emes RD; Wessely F; Yacqub-Usman K; Clayton RN; Farrell WE
Endocr Relat Cancer; 2012 Dec; 19(6):805-16. PubMed ID: 23045325
[TBL] [Abstract][Full Text] [Related]
10. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.
Paez-Pereda M; Giacomini D; Refojo D; Nagashima AC; Hopfner U; Grubler Y; Chervin A; Goldberg V; Goya R; Hentges ST; Low MJ; Holsboer F; Stalla GK; Arzt E
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1034-9. PubMed ID: 12552124
[TBL] [Abstract][Full Text] [Related]
11. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
[TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.
Wen XZ; Akiyama Y; Baylin SB; Yuasa Y
Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic mechanisms of tumorigenesis.
Farrell WE
Horm Metab Res; 2005 Jun; 37(6):361-8. PubMed ID: 16001328
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of histone modifications by ChIP-chip to identify silenced genes in gastric cancer.
Zhu X; Liu J; Xu X; Zhang C; Dai D
Oncol Rep; 2015 May; 33(5):2567-74. PubMed ID: 25738530
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a novel pituitary tumor apoptosis gene.
Bahar A; Simpson DJ; Cutty SJ; Bicknell JE; Hoban PR; Holley S; Mourtada-Maarabouni M; Williams GT; Clayton RN; Farrell WE
Mol Endocrinol; 2004 Jul; 18(7):1827-39. PubMed ID: 15105437
[TBL] [Abstract][Full Text] [Related]
16. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
[TBL] [Abstract][Full Text] [Related]
17. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
18. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
Bello MJ; De Campos JM; Isla A; Casartelli C; Rey JA
Oncol Rep; 2006 Feb; 15(2):443-8. PubMed ID: 16391867
[TBL] [Abstract][Full Text] [Related]
19. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
[TBL] [Abstract][Full Text] [Related]
20. [New mechanisms involved in the pathogenesis of pituitary adenomas].
Giacomini D; Páez-Pereda M; Refojo D; Carbia Nagashima A; Chervin A; Goldberg V; Arzt E
Medicina (B Aires); 2003; 63(2):147-50. PubMed ID: 12793085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
